Clover Health Investments (CLOV) to Release Quarterly Earnings on Tuesday

Clover Health Investments (NASDAQ:CLOV - Get Free Report) is expected to be issuing its Q1 2025 quarterly earnings data after the market closes on Tuesday, May 6th. Analysts expect Clover Health Investments to post earnings of ($0.07) per share and revenue of $466.93 million for the quarter.

Clover Health Investments Price Performance

Shares of Clover Health Investments stock traded up $0.02 during trading on Friday, hitting $3.34. 5,008,710 shares of the company's stock traded hands, compared to its average volume of 6,855,469. Clover Health Investments has a 1 year low of $0.69 and a 1 year high of $4.87. The business has a 50-day simple moving average of $3.61 and a 200-day simple moving average of $3.72. The stock has a market capitalization of $1.71 billion, a P/E ratio of -16.70 and a beta of 1.99.

Insider Buying and Selling

In other Clover Health Investments news, General Counsel Karen Soares sold 52,500 shares of the business's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $3.80, for a total transaction of $199,500.00. Following the completion of the sale, the general counsel now directly owns 1,299,663 shares in the company, valued at $4,938,719.40. The trade was a 3.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Brady Patrick Priest sold 75,000 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $3.68, for a total transaction of $276,000.00. Following the sale, the chief executive officer now directly owns 2,418,151 shares of the company's stock, valued at $8,898,795.68. The trade was a 3.01 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 327,500 shares of company stock valued at $1,197,500 over the last 90 days. Company insiders own 22.28% of the company's stock.

Analyst Ratings Changes

Separately, Canaccord Genuity Group boosted their price objective on shares of Clover Health Investments from $4.20 to $4.50 and gave the company a "buy" rating in a report on Monday, March 3rd.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.